Overview

This trial is active, not recruiting.

Conditions depression, asthma, urticaria
Treatment brief behavioral activation intervention
Sponsor University of Mississippi Medical Center
Start date May 2015
End date March 2016
Trial size 18 participants
Trial identifier NCT02382562, 2014-0340

Summary

Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in helping with depression and controlling disease symptoms. We will measure this using pre- and post-intervention surveys.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
All eligible participants will undergo the Brief Behavioral Activation Intervention.
brief behavioral activation intervention
Clinical psychologists (investigators) will instruct the participant in ways to become more active in life, particularly with regards to activities that the participant finds pleasurable and meaningful. The intervention will take one hour to complete. Following the intervention, the participant will receive brief, weekly text or email reminders for the next 4 weeks (total of 4) to engage in pleasurable and meaningful activities during the week.

Primary Outcomes

Measure
Asthma Control Test
time frame: 4 weeks
Urticaria Control Test
time frame: 4 weeks

Secondary Outcomes

Measure
Asthma Quality of Life Questionnaire
time frame: 4 weeks
Urticaria Activity Score Questionnaire
time frame: 4 weeks
Psychological Measures (Composite)
time frame: 4 weeks

Eligibility Criteria

Male or female participants from 18 years up to 64 years old.

Inclusion Criteria: - Potential participants should be between the ages 18 and 64, seen in the UMMC Allergy Clinic with either asthma or urticaria and who report symptoms of depression in the previous 2 weeks. Exclusion Criteria: - Potential participants younger than 18 and older than 64 or who do not speak English or cannot comprehend the consent form or women who are pregnant are excluded.

Additional Information

Official title Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients
Principal investigator Gailen D Marshall, Jr., MD, PhD
Description The purpose of this research study is to investigate whether a one-session behavioral activation intervention for depression can successfully reduce depression and improve asthma or urticaria disease-relevant outcomes (medication adherence, doctor's visits, substance abuse) in clinical patients with asthma or urticaria who report heightened levels of depression and are seen in the UMMC Allergy Clinic.
Trial information was received from ClinicalTrials.gov and was last updated in May 2016.
Information provided to ClinicalTrials.gov by University of Mississippi Medical Center.